Investors

2014 News Releases

Keyword Search
 
2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004
March 13, 2014
Codexis Sells Its Hungarian Operations to Intrexon Corporation
REDWOOD CITY, Calif., March 13, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the sale of its subsidiary in Hungary to Intrexon Corporation. The transaction closed on March 13, 2014, with a purchase price of $1.5 million. No proprietary Codexis materials or intellectual property were included in the transaction. "We are very pleased with this transaction," said John Nicols, Presid... 
March 11, 2014
Codexis Reports Fourth Quarter and Full Year 2013 Results
Conference Call Today at 4:30 pm ET REDWOOD CITY, Calif., March 11, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its financial results for the fourth quarter and year ended December 31, 2013. "We had a strong finish in 2013 as we executed well on our restructuring plans and delivered a solid financial result in the fourth quarter in our core biocatalysts business," said John Nic... 
February 27, 2014
Codexis Appoints Biopharmaceuticals Industry Veteran, Patrick Yang, Ph.D., to Board of Directors
REDWOOD CITY, Calif., Feb. 27, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the appointment of Patrick Yang, Ph.D., to its board of directors. Dr. Yang brings significant experience in pharmaceutical manufacturing and process development to the Codexis board, following several executive leadership roles within the pharmaceutical industry. John Nicols, President and CEO of Codexis... 
February 25, 2014
Codexis to Announce Fourth Quarter and Fiscal Year 2013 Financial Results on March 11, 2014
REDWOOD CITY, Calif., Feb. 25, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will host a live conference call and audio webcast on Tuesday, March 11, 2014 at 4:30 p.m. Eastern Time to discuss its fourth quarter and fiscal year 2013 financial results for the period ended December 31, 2013. The call and webcast will follow the release of fourth quarter and fiscal year financial resul... 
February 04, 2014
Codexis to Present at 16th Annual BIO CEO & Investor Conference
REDWOOD CITY, Calif., Feb. 4, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and complex chemistry industries, today announced that John Nicols, President and CEO of Codexis, will present a company overview at the 16th Annual BIO CEO & Investor Conference on Tuesday, February 11, 2014 at 1:00 p.m. ET in New York City. A live webcast and replay will be available on the Investors section of the company's website, http://ir.c... 
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS |

Share Page

X
| E-mail Alerts E-mail Alerts | IR Contacts Contacts | Financial Tear Sheet Tear Sheet

WE ARE BIOCATALYSISTM

We are an industrial biotechnology company delivering real business results through biobased innovation in chemicals, fuels, pharmaceuticals, consumer, and industrial products.

PHARMACEUTICAL ENZYMES


Supporting faster, cleaner, more efficient pharmaceutical manufacturing processes

Codexis delivers a range of chemicals at kilogram to multi-ton scale, through a partnered manufacturing network

CODEXIS

WHAT WE DO


Codexis delivers revolutionary biocatalytic routes that no one else can


CODEXIS

MEDIA CENTER


Visit our Media Center for the latest product information, videos, imagery, technical papers and press information.


CAREERS AT CODEXIS

An opportunity to make a difference.

Continued success at Codexis depends on the innovation, collaboration and commitment of people who are passionate about what they do


CODEXIS

INVESTOR CENTER


Access to Codexis information
for the investment community

built@zoomedia
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue